Overview

Intravenous Dexmedetomidine for Cesarean Section

Status:
Completed
Trial end date:
2017-10-05
Target enrollment:
Participant gender:
Summary
Nervous, anxiety, fear and other psychological reactions always appears in parturients during cesarean section. This study intends to investigate the effectiveness and safety of dexmedetomidine combined with butorphanol tartrate for postoperative analgesia and breastfeeding after caesarean section.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Treatments:
Butorphanol
Dexmedetomidine